May 26, 2017
Jay R. Lieberman, MD, chair and professor of orthopedic surgery at Keck School of Medicine of the University of Southern California received a 5-year, $2.2 million grant from the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases for gene therapy research to enhance repair of extensive bone injuries, according to a press release.
According to the release, Lieberman’s research will seek to genetically manipulate human bone marrow cells to overexpress bone morphogenetic protein (BMP). The study will reportedly determine the efficacy and safety of gene therapy. In addition, Lieberman will attempt to establish a cellular dose of genetically manipulated cells that can be scaled up and potentially be used in humans.